# Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation

> **NCT00980278** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 26 (actual)

## Conditions studied

- Tooth Loss

## Interventions

- **PROCEDURE:** Sinus lift augmentation and dental implant
- **BIOLOGICAL:** Aastrom BRCs

## Key facts

- **NCT ID:** NCT00980278
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980278, "Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00980278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
